IMMUNOSUPPRESSION
Clinical trials for IMMUNOSUPPRESSION explained in plain language.
Never miss a new study
Get alerted when new IMMUNOSUPPRESSION trials appear
Sign up with your email to follow new studies for IMMUNOSUPPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can the shingles vaccine protect transplant patients? new study aims to find out
⭐️ VACCINE ⭐️ Recruiting nowThis study tests the shingles vaccine (SHINGRIX) in 160 people: transplant recipients on different immunosuppressant drugs and their healthy housemates. Researchers will measure immune responses at five time points over a year to see if the vaccine works well in these groups. The…
Matched conditions: IMMUNOSUPPRESSION
Phase: NA • Sponsor: Central Adelaide Local Health Network Incorporated • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
Hand transplants get a boost: new drug may reduce rejection risk
Disease control Recruiting nowThis phase 2 study tests whether a hand transplant from a deceased donor, combined with the immunosuppressant belatacept (Nulojix), can help people with below-elbow limb loss use their new hand in daily tasks. Fifty participants aged 18-65 will be followed for 18 months. The main…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE2 • Sponsor: Linda Cendales • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could one pill a day keep the transplant safe?
Disease control Recruiting nowThis study tests whether taking immunosuppressant drugs just once daily after a liver transplant is as safe and effective as the standard twice-daily schedule. The goal is to make it easier for patients to stick with their lifelong medication, which could improve their quality of…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE4 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for kids with Crohn's: drug combo trial launches
Disease control Recruiting nowThis study compares two treatments for children aged 6-18 with Crohn's disease: one group gets infliximab alone, another gets immunosuppressives alone, and a third gets both. The goal is to see which approach leads to more kids achieving remission (feeling better and showing heal…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE4 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Liver transplant patients may cut lifelong drugs with simple ultrasound test
Disease control Recruiting nowThis study tests whether a special ultrasound called a fibroscan can help doctors safely lower the dose of anti-rejection drugs in liver transplant recipients. Participants must be at least 2 years post-transplant, have normal liver blood tests, and not have autoimmune liver dise…
Matched conditions: IMMUNOSUPPRESSION
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Gene test before kidney transplant could prevent drug dosing errors
Disease control Recruiting nowThis study tests whether checking a patient's genes before a kidney transplant can help doctors choose the best starting dose of the anti-rejection drug tacrolimus. About 114 adults on the transplant waiting list will be randomly assigned to either standard dosing or a dose based…
Matched conditions: IMMUNOSUPPRESSION
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 26, 2026 16:21 UTC
-
Scientists dig into mouth bacteria to unlock immune secrets
Knowledge-focused Recruiting nowThis study looks at how genetic immune system problems might lead to gum disease and other mouth issues. Researchers will collect samples like saliva, plaque, and blood from 700 people, including those with immune defects, healthy adults with gum disease, and healthy adults witho…
Matched conditions: IMMUNOSUPPRESSION
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Trauma's hidden toll: new study probes blood changes that raise infection risk
Knowledge-focused Recruiting nowThis study looks at what happens to blood and bone marrow after a severe injury. Researchers want to understand why some trauma patients develop a weakened immune system and get serious infections like sepsis. About 255 adults with severe fractures will give blood and a small bon…
Matched conditions: IMMUNOSUPPRESSION
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC